X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Colgate - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs COLGATE - Comparison Results

COLGATE 
   Change

Colgate is present in oral care, personal care and household care products with oral care contributing more than 90% to overall revenues. Colgate dominates in this core business with market shares of 54.5% in toothpastes and 38.2% in toothbrushes. Th... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES COLGATE AMAR REMEDIES/
COLGATE
 
P/E (TTM) x -0.5 50.5 - View Chart
P/BV x 0.1 26.7 0.2% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 AMAR REMEDIES   COLGATE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
COLGATE
Mar-17
AMAR REMEDIES/
COLGATE
5-Yr Chart
Click to enlarge
High Rs1641,033 15.9%   
Low Rs86788 10.9%   
Sales per share (Unadj.) Rs261.6146.4 178.7%  
Earnings per share (Unadj.) Rs17.421.2 81.9%  
Cash flow per share (Unadj.) Rs22.326.1 85.3%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs100.746.8 215.1%  
Shares outstanding (eoy) m26.16271.99 9.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.56.2 7.7%   
Avg P/E ratio x7.242.9 16.8%  
P/CF ratio (eoy) x5.634.8 16.1%  
Price / Book Value ratio x1.219.4 6.4%  
Dividend payout %047.1 0.0%   
Avg Mkt Cap Rs m3,270247,579 1.3%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m1632,885 5.6%   
Avg. sales/employee Rs ThNM16,494.7-  
Avg. wages/employee Rs ThNM1,195.1-  
Avg. net profit/employee Rs ThNM2,392.0-  
INCOME DATA
Net Sales Rs m6,84439,818 17.2%  
Other income Rs m21398 5.3%   
Total revenues Rs m6,86540,216 17.1%   
Gross profit Rs m1,1319,449 12.0%  
Depreciation Rs m1281,332 9.6%   
Interest Rs m3980-   
Profit before tax Rs m6268,514 7.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1212,740 4.4%   
Profit after tax Rs m4555,774 7.9%  
Gross profit margin %16.523.7 69.6%  
Effective tax rate %19.332.2 60.1%   
Net profit margin %6.614.5 45.8%  
BALANCE SHEET DATA
Current assets Rs m4,9048,556 57.3%   
Current liabilities Rs m3,58110,496 34.1%   
Net working cap to sales %19.3-4.9 -396.8%  
Current ratio x1.40.8 168.0%  
Inventory Days Days12427 463.4%  
Debtors Days Days10012 841.1%  
Net fixed assets Rs m1,68912,747 13.3%   
Share capital Rs m262272 96.3%   
"Free" reserves Rs m2,35812,466 18.9%   
Net worth Rs m2,63512,738 20.7%   
Long term debt Rs m5070-   
Total assets Rs m6,86223,234 29.5%  
Interest coverage x2.6NM-  
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.7 58.2%   
Return on assets %12.424.9 50.0%  
Return on equity %17.345.3 38.1%  
Return on capital %31.066.8 46.4%  
Exports to sales %4.03.5 113.2%   
Imports to sales %00-   
Exports (fob) Rs m2731,403 19.5%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2731,607 17.0%   
Fx outflow Rs m20-   
Net fx Rs m2711,607 16.9%   
CASH FLOW
From Operations Rs m-3136,880 -4.5%  
From Investments Rs m-489-3,422 14.3%  
From Financial Activity Rs m769-3,405 -22.6%  
Net Cashflow Rs m-3353 -61.1%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 51.0 -  
Indian inst/Mut Fund % 9.2 7.0 131.4%  
FIIs % 0.0 20.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 22.1 295.5%  
Shareholders   13,061 131,569 9.9%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   EMAMI LTD  LINC PEN & PLASTICS LTD  MARICO LTD  P&G HYGIENE  GODREJ CONSUMER  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Surges 320 Points; ONGC Tanks 4.5%(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - LINC PEN & PLASTICS LTD COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS